Stay updated on Effectiveness and Duration of Vyvanse in ADHD Clinical Trial
Sign up to get notified when there's something new on the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page.

Latest updates to the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page
- Check6 days agoChange DetectedAdded New York as a location in the Locations section. Page revision updated to v3.3.3.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedPublications section wording updated to clarify that publications are automatically filled from PubMed and may not be about the study. The page revision tag shows a change from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check42 days agoChange DetectedDeleted the general maintenance notice about funding lapsed and NIH operations; the study page content remains unchanged.SummaryDifference0.4%

- Check56 days agoChange DetectedThe new screenshot shows only minor visual/layout updates with no changes to core study details such as the title, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check92 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to Effectiveness and Duration of Vyvanse in ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effectiveness and Duration of Vyvanse in ADHD Clinical Trial page.